Durila Miroslav, Kalincík Tomás, Pacáková Zuzana, Cvachovec Karel
Department of Anesthesiology and Critical Care Medicine, Second Faculty of Medicine and Institute for Postgraduate Medical Education, Charles University in Prague, Prague, Czech Republic.
Blood Coagul Fibrinolysis. 2010 Mar;21(2):192-5. doi: 10.1097/MBC.0b013e3283338c0d.
Heparin is commonly used to prevent obstruction of indwelling arterial catheters with blood clots. It is known to affect the outcomes of analysis of coagulation parameters with thromboelastography (TEG); therefore, it has been recommended to neutralize its effect with heparinase. However, heparinase may also neutralize the effect of low molecular weight heparin and endogenous heparinoids present in critically ill patients and thus yields unreliable results. The aim of this study was to evaluate the minimal discard blood volume needed to eliminate the effect of heparin flush on TEG parameters without the use of heparinase. Ten patients with indwelling arterial catheter were included in the study. Coagulation parameters were evaluated with kaolin-activated TEG. Blood samples were obtained after discarding 1, 2, 3, 4, 5 or 10 ml of blood to eliminate the effect of heparin. We investigated the influence of the discard volume on time until the first detectable clot (R), speed of clot development (alpha angle), maximal amplitude of the measured clot and time to maximal amplitude of the measured clot. We found an increase in coagulation (reflecting the heparin elimination) with the increasing discard volume between 1 and 4 ml. This was obvious from an increase in alpha angle and maximal amplitude of the measured clot and a decrease in R and time to maximal amplitude of the measured clot (P < 0.001). However, values obtained after discarding 4, 5 and 10 ml of blood did not differ markedly. To obtain valid information about TEG parameters, it is necessary to discard volume of at least 4 ml of blood (i.e., five times the volume of catheter dead space).
肝素常用于预防留置动脉导管被血凝块阻塞。已知它会影响血栓弹力图(TEG)对凝血参数的分析结果;因此,建议用肝素酶中和其作用。然而,肝素酶也可能中和重症患者体内低分子量肝素和内源性类肝素的作用,从而产生不可靠的结果。本研究的目的是评估在不使用肝素酶的情况下,消除肝素封管对TEG参数影响所需的最小弃血量。本研究纳入了10例留置动脉导管的患者。采用高岭土激活的TEG评估凝血参数。丢弃1、2、3、4、5或10毫升血液后采集血样,以消除肝素的影响。我们研究了弃血量对首次检测到血凝块的时间(R)、血凝块形成速度(α角)、所测血凝块的最大振幅以及达到所测血凝块最大振幅的时间的影响。我们发现,弃血量在1至4毫升之间增加时,凝血功能增强(反映肝素被清除)。这从α角和所测血凝块最大振幅增加,以及R和达到所测血凝块最大振幅的时间减少可以明显看出(P<0.001)。然而,丢弃4、5和10毫升血液后获得的值没有显著差异。为了获得关于TEG参数的有效信息,有必要丢弃至少4毫升血液(即导管死腔容积的五倍)。